S-Nitrosoglutathione不是OATP1B1的基质,但可以刺激其表达和活动
Yulia V Abalenikhina1, Aleksey V Shchulkin2, Olga N Suchkova1
1Department of Biological Chemistry, Ryazan State Medical University, 390026 Ryazan, Russia.
Biomolecules
|March 28, 2025
概括
虽然S-酸氨酸 (GSNO) 不使用OATP1B1转运体,但它可以调节它. 长期的GSNO暴露通过特定的信号通路对OATP1B1的表达和活性进行上调.
科学领域:
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
- 分子生物学分子生物学
背景情况:
- 酸 (GSNO) 是一种内源性氧化 (NO) 供体.
- 有机离子运输聚1B1 (OATP1B1) 是各种物质的肝脏关键运输体.
研究的目的:
- 研究OATP1B1在GSNO运输中的作用.
- 研究GSNO对OATP1B1表达和活性的影响.
主要方法:
- 使用了稳定表达OATP1B1的HEK293细胞.
- 进行了GSNO和谷氨 (GSH) 运输测定.
- 在GSNO暴露后测量了基因表达,蛋白质水平和输送活性.
主要成果:
- GSNO不是OATP1B1的基质,但OATP1B1可以促进GSH的传输.
- 短期GSNO暴露 (3小时) 并没有改变OATP1B1.1.
- 长期的GSNO暴露 (24-72小时) 显著上调SLCO1B1基因表达,OATP1B1蛋白水平和转运体活性.
结论:
- 通过NO-cGMP,Nrf2和LXRα信号通路,GSNO调节OATP1B1的表达和活动.
- OATP1B1并不直接参与GSNO运输,但受到GSNO的调节,影响细胞谷氨稳定.
更多相关视频
相关概念视频
Drug Metabolism: Phase II Reactions
4.7K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
4.7K
Carrier-Mediated Transport
1.6K
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
1.6K
Phase II Reactions: Glucuronidation
2.2K
Glucuronidation, a pivotal phase II biotransformation process, involves the coupling of glucuronic acid to a drug or xenobiotic. Given its widespread occurrence and critical role in drug metabolism, it's considered the most crucial phase II reaction. It enhances the water solubility of substances, aiding their expulsion from the body. The driving force behind these reactions is a group of enzymes known as UDP-glucuronosyltransferases (UGTs). UGTs facilitate the transfer of a glucuronic acid...
2.2K
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
1.3K
Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
1.3K
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
94
Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
94
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
189
The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
189


